Thu, November 7, 2019

Travis Steed Maintained (AXGN) at Buy with Decreased Target to $19 on, Nov 7th, 2019

Travis Steed of Cantor Fitzgerald, Maintained "AxoGen, Inc." (AXGN) at Buy with Decreased Target from $21 to $19 on, Nov 7th, 2019.

Travis, nor any peers, have made any analyst calls on AXGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30